Funds with similar focus
Fund Name | Location |
819 Capital | California, San Francisco, United States |
Berwind Private Equity | Harvard, Massachusetts, United States |
Closed Loop Ventures | New City, New York, United States |
Ericsson Ventures | California, Santa Clara, United States |
Holtzbrinck Digital | Bayern, Germany, München |
Hongrui Touzi | China, Jiading, Shanghai |
Insight Capital | Beijing, Beijing, China |
KPIT Technologies | India, Maharashtra, Pune |
Life.SREDA | Central, Central Region, Singapore |
Maker Institute CAS | China, Guangdong, Tianjin |
MCM Capital Partners | Beachwood, Ohio, United States |
Merian Global Investors | England, London, United Kingdom |
Nanoholdings | - |
Nobori | - |
Platinum-Montaur Life Sciences | New York, New York, United States |
PPL | Allentown, Pennsylvania, United States |
Renovus Capital Partners | Pennsylvania, United States, Wynnewood |
Seashell Capital | Beijing, Beijing, China |
Vicente Capital Partners | California, Los Angeles, United States |
XN | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
IGEM Therapeutics | $17M | 09 Sep 2024 | London, England, United Kingdom | ||
Vantage Biosciences | 19 Jul 2023 | London, England, United Kingdom | |||
Jatri | $5M | 15 Apr 2023 | Dhaka, Dhaka Division, Bangladesh | ||
IGEM Therapeutics | $42M | 02 Mar 2022 | London, England, United Kingdom | ||
Promatix | 08 Mar 2021 | London, England, United Kingdom | |||
Montis Biosciences | $9M | 20 Feb 2020 | Belgium, Flemish Brabant, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
IGEM Therapeutics | $17M | 09 Sep 2024 | London, England, United Kingdom | ||
Vantage Biosciences | 19 Jul 2023 | London, England, United Kingdom | |||
Jatri | $5M | 15 Apr 2023 | Dhaka, Dhaka Division, Bangladesh | ||
IGEM Therapeutics | $42M | 02 Mar 2022 | London, England, United Kingdom | ||
Promatix | 08 Mar 2021 | London, England, United Kingdom | |||
Montis Biosciences | $9M | 20 Feb 2020 | Belgium, Flemish Brabant, Belgium |